CaMK2 modulators and their use in medicine

Research output: Patent

The present disclosure relates to compounds which bind Ca2+/calmodulin dependent protein kinase II. It also relates to such compounds for use in the treatment of CNS disorders with sleep disturbances and acute brain injury.
Original languageEnglish
Patent numberWO2023170024A1
Filing date01/01/1970
Country/TerritoryUnited States
Priority numberUS202263318852P
Publication statusPublished - 2023

ID: 382744669